In this episode, Omar Khateeb sits down with Chris Darland, President & CEO of Peerbridge Health, to explore how AI, high fidelity ECG data, and wearable monitoring could reshape the future of preventive cardiology.
Chris shares the personal story behind Peerbridge Health and why the company is focused on one of healthcare’s biggest challenges: cardiac care is still highly reactive. Most patients only enter the system after an emergency event, despite heart disease developing over years.
The conversation dives into Peerbridge’s vision for a new category called the cardiac intelligence platform, combining advanced ECG signal fidelity, AI driven interpretation, and personalized software layers to help clinicians identify myocardial stress, structural defects, arrhythmias, and other cardiac risks earlier.
They also explore how scalable monitoring could improve triage, reduce unnecessary referrals, support primary care physicians, and help health systems identify the right patients before they reach crisis.
This episode is a deep look into where digital cardiology, preventive care, AI infrastructure, and personalized diagnostics are heading next.
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Episode Breakdown
00:00 Why Cardiac Care is Still Reactive
00:53 Intro + Chris Darland and Peerbridge Health
02:00 Growing Up Around Heart Disease
04:30 From GE to MedTech Startup CEO
05:20 The Real Problem in Cardiology Today
06:49 Scaling Cardiac Care Beyond Hospitals
08:00 Heart Failure and Readmission Crisis
09:00 Arrhythmia Monitoring Explained
10:00 Beyond Arrhythmias: Structural Heart Detection
12:00 AI + ECG for Earlier Detection
13:58 Why Most MedTech Startups Fail After FDA
14:05 Cardiac Intelligence Platform Explained
16:00 Using ECG Data to Detect Heart Disease Early
18:00 Why Signal Fidelity Matters
19:30 AI Layer for Personalized Cardiac Insights
21:30 Building a Defensible AI MedTech Company
23:00 Why Hardware + Unique Data Matter
24:08 Regulatory Strategy and FDA Pathway
26:11 Why MedTech Has Strong AI Defensibility
27:30 NASA Signal Processing and SpaceTech Crossover
29:15 Strategic Partnerships and Acquisition Potential
31:00 Detecting Patients Before Critical Events
33:35 AI Triage for Primary Care and Cardiology
36:00 Reducing Unnecessary Specialist Visits
37:39 Using AI to Route Patients to the Right Hospital
39:00 Fundraising and Strategic Investors
41:00 Clinical Trials and Real-World Evidence
43:14 Early Trial Results and Heart Failure Detection
44:09 The Future of AI-Powered Cardiac Care
45:25 Why Mission Matters More Than Exit Price
47:40 Outro
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
Subscribe to our LinkedIn Newsletter
Follow The State of MedTech on
Follow Omar M. Khateeb on
#cardiology #medtech #aiinhealthcare #digitalhealth #healthcareinnovation
Comments
Want to join the conversation?
Loading comments...